Caldesmon Antikörper (Center, Internal Region)
-
- Target Alle Caldesmon (CALD1) Antikörper anzeigen
- Caldesmon (CALD1) (Caldesmon 1 (CALD1))
-
Bindungsspezifität
- AA 435-465, Center, Internal Region
-
Reaktivität
- Human
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser Caldesmon Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB), Immunohistochemistry (IHC), ELISA, Flow Cytometry (FACS)
- Kreuzreaktivität
- Human
- Kreuzreaktivität (Details)
- Calculated cross reactivity: Hu
- Produktmerkmale
- CALD1, ID (Caldesmon, CDM, CAD, CALD1)
- Aufreinigung
- Purified by ammonium sulfate precipitation.
- Immunogen
- KLH-conjugated synthetic peptide corresponding to a portion of amino acids within aa435-465 from the center region of human CALD1 (Accession #Q05682).
- Isotyp
- IgG
- Top Product
- Discover our top product CALD1 Primärantikörper
-
-
- Applikationshinweise
- Optimal working conditions should be determined by the investigator.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Buffer
- Supplied as a liquid in PBS, 0.09 % sodium azide
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- -20°C
-
- Target
- Caldesmon (CALD1) (Caldesmon 1 (CALD1))
- Andere Bezeichnung
- CALD1 (CALD1 Produkte)
- NCBI Accession
- NP_004333
- UniProt
- Q05682
- Pathways
- Myometrial Relaxation and Contraction
-